Martin Shkreli, the pharma entrepreneur who became notorious in 2015 for hiking the price of a lifesaving drug, has been sentenced to seven years in prison for fraud.
Pfizer has been steadily building a franchise around its inflammatory diseases pill, Xeljanz (tofacitinib) over the last few years, and it could add another use after US experts recommended
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
